Authors | Setting | Study design | Sample size SCD/controls | Renal function |
---|---|---|---|---|
Kambale-Kombi et al 2022 | Kisangani, D R Congo | Prospective case-control study | 98/89 | creatinine mean = 52.59, sd = 18.59; urea mean = 5.05, sd = 1.82; eGFR mean = 119.90, sd = 53.78 [10] |
Ndour et al. 2022 | Dakar, Senegal | Prospective case-control study | 163/177 | creatinine mean = 52.17, sd = 20.34; urea mean = 7.00, sd = 4.50 [12] |
Olawale et al. 2021 | South-west, Nigeria | Prospective case-control study | 150/50 | creatinine mean = 47.75, sd = 0.88; urea mean = 16.80, sd = 1.30; eGFR mean = 122.50, sd = 9.00 [16] |
Suliman et al. 2020 | Khartoum, Sudan | Prospective case-control study | 32/23 | creatinine mean = 57.47, sd = 15.92; urea mean = 21.60, sd = 8.40; eGFR mean = 149.70, sd = 29.60 [17] |
Nnaji et al. 2020 | Owerri, Nigeria | Prospective case-control study | 60/60 | creatinine mean = 44.24, sd = 17.68; eGFR mean = 146.50, sd = 31.10 [13] |
Farouk et al. 2020 | Maiduguri, Nigeria | Prospective case-control study | 110/110 | eGFR mean = 125.90, sd = 31.90 [9] |
Tantaway et al. 2017 | Cairo, Egypt | Prospective case-control study | 53/40 | Creatinine mean = 43.33, sd = 8.84 [18] |
Obalide et al. 2017 | Lagos, Nigeria | Prospective case-control study | 20 / 20 | creatinine mean = 54.90, sd = 21.73; eGFR mean = 130.24, sd = 42.57 [14] |
Aloni et al. 2014 | Kinshasa, D R Congo | Prospective case-control study | 65 / 67 | creatinine mean = 44.21, sd = 11.49; urea mean = 15.30, sd = 8.30; eGFR mean = 130.50, sd = 34.10 [6] |
Asaolu et al. 2010 | Ekiti, Nigeria | Prospective case-control study | 42 / 42 | creatinine mean = 10.55, sd = 8.13; urea mean = 10.50, sd = 6.28 [7] |
Mohamed et al. 1992 | Khartoum, Sudan | Prospective case-control study | 84 / 28 | creatinine mean = 22.20, sd = 4.00; urea mean = 22.70, sd = 5.70 [11] |
El-Gamasy and El-Naghy 2019 | Tanta, Egypt | Prospective case-control study | 70 / 40 | creatinine mean = 90.19, sd = 17.68; urea mean = 22.90, sd = 7.60 [8] |
Okoro and Onwuameze 1991 | Enugu, Nigeria | Prospective case-control study | 60 / 305 | eGFR mean = 111, sd = 36.0 [15] |